KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adient (ADNT) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Adient (ADNT) over the last 11 years, with Q4 2025 value amounting to $65.0 million.

  • Adient's Capital Expenditures rose 156.25% to $65.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $246.0 million, marking a year-over-year decrease of 1054.55%. This contributed to the annual value of $245.0 million for FY2025, which is 789.47% down from last year.
  • Adient's Capital Expenditures amounted to $65.0 million in Q4 2025, which was up 156.25% from $79.0 million recorded in Q3 2025.
  • Adient's Capital Expenditures' 5-year high stood at $79.0 million during Q3 2025, with a 5-year trough of $45.0 million in Q1 2025.
  • Its 5-year average for Capital Expenditures is $62.2 million, with a median of $60.0 million in 2021.
  • Per our database at Business Quant, Adient's Capital Expenditures crashed by 4148.94% in 2021 and then soared by 3157.89% in 2023.
  • Adient's Capital Expenditures (Quarter) stood at $60.0 million in 2021, then grew by 1.67% to $61.0 million in 2022, then fell by 9.84% to $55.0 million in 2023, then grew by 16.36% to $64.0 million in 2024, then rose by 1.56% to $65.0 million in 2025.
  • Its Capital Expenditures stands at $65.0 million for Q4 2025, versus $79.0 million for Q3 2025 and $57.0 million for Q2 2025.